
Professor Yu Jie Zhou
Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)
Membership:
FESC Member
Follow
Contributor content
Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
Presentation

